Report Detail

Request for Sample of this report

Other Global Mucopolysaccharidosis (MPS) Treatment

  • RnM3475251
    • |
  • 30 May, 2019
    • |
  • Global
    • |
  • 130 Pages
    • |
  • LPI(LP Information)
    • |
  • Other

Mucopolysaccharidoses are a group of metabolic disorders caused by the absence or malfunctioning of lysosomal enzymes needed to break down molecules called glycosaminoglycans. These long chains of sugar carbohydrates occur within the cells that help build bone, cartilage, tendons, corneas, skin and connective tissue. Glycosaminoglycans (formerly called mucopolysaccharides) are also found in the fluids that lubricate joints.

According to this study, over the next five years the Mucopolysaccharidosis (MPS) Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Mucopolysaccharidosis (MPS) Treatment business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Mucopolysaccharidosis (MPS) Treatment market by product type, application, key companies and key regions.

This study considers the Mucopolysaccharidosis (MPS) Treatment value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Stem Cell Therapies
Enzyme Replacement Therapies
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospitals
Clinics
Homecare

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sanofi
Shire (Takeda)
BioMarin Pharmaceutical
Esteve
REGENXBIO Inc
Sangamo Therapeutics
Ultragenyx Pharmaceutical
Abeona Therapeutics
ArmaGen
Eloxx Pharmaceuticals
Inventiva

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Mucopolysaccharidosis (MPS) Treatment market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Mucopolysaccharidosis (MPS) Treatment market by identifying its various subsegments.
Focuses on the key global Mucopolysaccharidosis (MPS) Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Mucopolysaccharidosis (MPS) Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Mucopolysaccharidosis (MPS) Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global Mucopolysaccharidosis (MPS) Treatment Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Mucopolysaccharidosis (MPS) Treatment Market Size 2014-2024
        • 2.1.2 Mucopolysaccharidosis (MPS) Treatment Market Size CAGR by Region
      • 2.2 Mucopolysaccharidosis (MPS) Treatment Segment by Type
        • 2.2.1 Stem Cell Therapies
        • 2.2.2 Enzyme Replacement Therapies
      • 2.3 Mucopolysaccharidosis (MPS) Treatment Market Size by Type
        • 2.3.1 Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global Mucopolysaccharidosis (MPS) Treatment Market Size Growth Rate by Type (2014-2019)
      • 2.4 Mucopolysaccharidosis (MPS) Treatment Segment by Application
        • 2.4.1 Hospitals
        • 2.4.2 Clinics
        • 2.4.3 Homecare
      • 2.5 Mucopolysaccharidosis (MPS) Treatment Market Size by Application
        • 2.5.1 Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global Mucopolysaccharidosis (MPS) Treatment Market Size Growth Rate by Application (2014-2019)

      3 Global Mucopolysaccharidosis (MPS) Treatment by Players

      • 3.1 Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Players
        • 3.1.1 Global Mucopolysaccharidosis (MPS) Treatment Market Size by Players (2017-2019)
        • 3.1.2 Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Players (2017-2019)
      • 3.2 Global Mucopolysaccharidosis (MPS) Treatment Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Mucopolysaccharidosis (MPS) Treatment by Regions

      • 4.1 Mucopolysaccharidosis (MPS) Treatment Market Size by Regions
      • 4.2 Americas Mucopolysaccharidosis (MPS) Treatment Market Size Growth
      • 4.3 APAC Mucopolysaccharidosis (MPS) Treatment Market Size Growth
      • 4.4 Europe Mucopolysaccharidosis (MPS) Treatment Market Size Growth
      • 4.5 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size Growth

      5 Americas

      • 5.1 Americas Mucopolysaccharidosis (MPS) Treatment Market Size by Countries
      • 5.2 Americas Mucopolysaccharidosis (MPS) Treatment Market Size by Type
      • 5.3 Americas Mucopolysaccharidosis (MPS) Treatment Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Mucopolysaccharidosis (MPS) Treatment Market Size by Countries
      • 6.2 APAC Mucopolysaccharidosis (MPS) Treatment Market Size by Type
      • 6.3 APAC Mucopolysaccharidosis (MPS) Treatment Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Mucopolysaccharidosis (MPS) Treatment by Countries
      • 7.2 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Type
      • 7.3 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment by Countries
      • 8.2 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Type
      • 8.3 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Mucopolysaccharidosis (MPS) Treatment Market Forecast

      • 10.1 Global Mucopolysaccharidosis (MPS) Treatment Market Size Forecast (2019-2024)
      • 10.2 Global Mucopolysaccharidosis (MPS) Treatment Forecast by Regions
        • 10.2.1 Global Mucopolysaccharidosis (MPS) Treatment Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Mucopolysaccharidosis (MPS) Treatment Forecast by Type
      • 10.8 Global Mucopolysaccharidosis (MPS) Treatment Forecast by Application

      11 Key Players Analysis

      • 11.1 Sanofi
        • 11.1.1 Company Details
        • 11.1.2 Mucopolysaccharidosis (MPS) Treatment Product Offered
        • 11.1.3 Sanofi Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 Sanofi News
      • 11.2 Shire (Takeda)
        • 11.2.1 Company Details
        • 11.2.2 Mucopolysaccharidosis (MPS) Treatment Product Offered
        • 11.2.3 Shire (Takeda) Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 Shire (Takeda) News
      • 11.3 BioMarin Pharmaceutical
        • 11.3.1 Company Details
        • 11.3.2 Mucopolysaccharidosis (MPS) Treatment Product Offered
        • 11.3.3 BioMarin Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 BioMarin Pharmaceutical News
      • 11.4 Esteve
        • 11.4.1 Company Details
        • 11.4.2 Mucopolysaccharidosis (MPS) Treatment Product Offered
        • 11.4.3 Esteve Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 Esteve News
      • 11.5 REGENXBIO Inc
        • 11.5.1 Company Details
        • 11.5.2 Mucopolysaccharidosis (MPS) Treatment Product Offered
        • 11.5.3 REGENXBIO Inc Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 REGENXBIO Inc News
      • 11.6 Sangamo Therapeutics
        • 11.6.1 Company Details
        • 11.6.2 Mucopolysaccharidosis (MPS) Treatment Product Offered
        • 11.6.3 Sangamo Therapeutics Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 Sangamo Therapeutics News
      • 11.7 Ultragenyx Pharmaceutical
        • 11.7.1 Company Details
        • 11.7.2 Mucopolysaccharidosis (MPS) Treatment Product Offered
        • 11.7.3 Ultragenyx Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.7.4 Main Business Overview
        • 11.7.5 Ultragenyx Pharmaceutical News
      • 11.8 Abeona Therapeutics
        • 11.8.1 Company Details
        • 11.8.2 Mucopolysaccharidosis (MPS) Treatment Product Offered
        • 11.8.3 Abeona Therapeutics Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.8.4 Main Business Overview
        • 11.8.5 Abeona Therapeutics News
      • 11.9 ArmaGen
        • 11.9.1 Company Details
        • 11.9.2 Mucopolysaccharidosis (MPS) Treatment Product Offered
        • 11.9.3 ArmaGen Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.9.4 Main Business Overview
        • 11.9.5 ArmaGen News
      • 11.10 Eloxx Pharmaceuticals
        • 11.10.1 Company Details
        • 11.10.2 Mucopolysaccharidosis (MPS) Treatment Product Offered
        • 11.10.3 Eloxx Pharmaceuticals Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.10.4 Main Business Overview
        • 11.10.5 Eloxx Pharmaceuticals News
      • 11.11 Inventiva

      12 Research Findings and Conclusion

      Summary:
      Get latest Market Research Reports on Mucopolysaccharidosis (MPS) Treatment . Industry analysis & Market Report on Mucopolysaccharidosis (MPS) Treatment is a syndicated market report, published as Global Mucopolysaccharidosis (MPS) Treatment . It is complete Research Study and Industry Analysis of Mucopolysaccharidosis (MPS) Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,660.00
      		$5,490.00
      		$7,320.00
      		2,928.00
      		4,392.00
      		5,856.00
      		3,531.90
      		5,297.85
      		7,063.80
      		578,206.80
      		867,310.20
      		1,156,413.60
      		314,137.80
      		471,206.70
      		628,275.60
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo